1. Home
  2. VTRS vs CAE Comparison

VTRS vs CAE Comparison

Compare VTRS & CAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VTRS
  • CAE
  • Stock Information
  • Founded
  • VTRS 1961
  • CAE 1947
  • Country
  • VTRS United States
  • CAE Canada
  • Employees
  • VTRS N/A
  • CAE N/A
  • Industry
  • VTRS Medicinal Chemicals and Botanical Products
  • CAE
  • Sector
  • VTRS Health Care
  • CAE
  • Exchange
  • VTRS Nasdaq
  • CAE Nasdaq
  • Market Cap
  • VTRS 9.0B
  • CAE 8.1B
  • IPO Year
  • VTRS N/A
  • CAE N/A
  • Fundamental
  • Price
  • VTRS $8.79
  • CAE $25.73
  • Analyst Decision
  • VTRS Hold
  • CAE Buy
  • Analyst Count
  • VTRS 4
  • CAE 3
  • Target Price
  • VTRS $10.50
  • CAE $32.33
  • AVG Volume (30 Days)
  • VTRS 17.6M
  • CAE 617.3K
  • Earning Date
  • VTRS 05-08-2025
  • CAE 05-13-2025
  • Dividend Yield
  • VTRS 5.46%
  • CAE N/A
  • EPS Growth
  • VTRS N/A
  • CAE N/A
  • EPS
  • VTRS N/A
  • CAE 0.88
  • Revenue
  • VTRS $14,330,200,000.00
  • CAE $3,275,402,649.00
  • Revenue This Year
  • VTRS N/A
  • CAE $8.43
  • Revenue Next Year
  • VTRS $1.85
  • CAE $5.82
  • P/E Ratio
  • VTRS N/A
  • CAE $29.17
  • Revenue Growth
  • VTRS N/A
  • CAE 9.93
  • 52 Week Low
  • VTRS $6.85
  • CAE $15.95
  • 52 Week High
  • VTRS $13.55
  • CAE $27.62
  • Technical
  • Relative Strength Index (RSI)
  • VTRS 54.57
  • CAE 56.45
  • Support Level
  • VTRS $8.19
  • CAE $24.63
  • Resistance Level
  • VTRS $8.85
  • CAE $26.10
  • Average True Range (ATR)
  • VTRS 0.25
  • CAE 0.67
  • MACD
  • VTRS 0.00
  • CAE -0.05
  • Stochastic Oscillator
  • VTRS 65.22
  • CAE 67.27

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About CAE CAE Inc.

CAE Inc provides training and aviation services, integrated enterprise solutions, in-service support, and crew-sourcing services. The company operations are managed through two segments: Civil Aviation which offers comprehensive training solutions for flight, cabin, maintenance, and ground personnel in commercial, business, and helicopter aviation, a complete range of flight simulation training devices, ab initio pilot training, and crew sourcing services, as well as aircraft flight operations solutions; and Defense and Security which is a global training and simulation provider delivering scalable, platform-independent solutions that enable and enhance force readiness and security. It generates the majority of its revenue from the Civil Aviation segment.

Share on Social Networks: